Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

The Construction method and application of type ii animal model of mucopolysaccharide storage disease

A technology of mucopolysaccharidosis and construction method, which is applied in the field of animal model construction, can solve the problems of harsh conditions, lack of researchable animal models, high cost, etc., and achieves the effect of short cycle

Active Publication Date: 2017-01-04
SHAANXI HUIKANG BIO TECH CO LTD
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Aiming at the complicated process, harsh conditions and huge cost in the construction of the current animal model, and the lack of researchable animal models in the current mucopolysaccharidosis type II research, the present invention provides a mucopolysaccharidosis type II Method for constructing animal model, animal model obtained by the method, and use of the animal model in the study of mucopolysaccharidosis type II

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The Construction method and application of type ii animal model of mucopolysaccharide storage disease
  • The Construction method and application of type ii animal model of mucopolysaccharide storage disease
  • The Construction method and application of type ii animal model of mucopolysaccharide storage disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0040] In order to fully understand the purpose, features and effects of the present invention, the present invention will be described in detail through the following specific embodiments, but the present invention is not limited thereto. For the experimental methods that do not specify specific conditions in the following specific embodiments, select according to conventional methods and conditions, or according to the product instructions. The substances involved in the following specific embodiments are conventionally commercially available.

[0041]The CRISPR / Cas9 gene knockout technology involved in the present invention is the latest generation method that can be used for site-specific construction of gene knockout mice after zinc finger nuclease, TALEN and other technologies, and shows great potential in directional gene modification. The present invention provides a mucopolysaccharidosis type II mouse animal model and its construction method based on CRISPR / Cas9 gene ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention provides a method for constructing type ii animal model of mucopolysaccharide storage disease, which comprises synthesizing the oligonucleotide strand and annealing annealing the pUC57 T7 SgRNA with it, then connect to gain a sgRNA expression vector according to the mouse iDS gene design target; to obtain a mouse fertilized egg; mix the transferred Cas9mRNA and sgRNA to obtain an RNA mixture, microinject the RNA mixture to the cytoplasm of that fertilized egg, then implant the it into the female mice to get a F0 generation mice; extract the genomic DNA of them and use them as a template to carry out PCR reaction. The product was digested and the mutant ones were selected to determine Founder Mice; Founder Mice and those wild male mice were mated to obtain F1 mice. The invention also provides an animal model constructed by this method and the usage of the model in the study of mucopolysaccharide sequestration type ii.

Description

technical field [0001] The invention belongs to the technical field of medical biology, in particular, the invention relates to a method for constructing an animal model. Background technique [0002] Mouse disease models play a key role in the study of human disease pathogenesis and drug screening, especially in the evaluation of drug treatment effects and the selection of treatment methods. [0003] Gene knockout is a new type of molecular biology technology developed since the late 1980s. It is a technology to inactivate or delete specific genes in the body through a certain way. Gene knockout in the general sense is mainly to apply the principle of DNA homologous recombination to replace the target gene fragment with a designed homologous fragment, so as to achieve the purpose of gene knockout. This is a complex molecular biology technology, also known as "gene targeting" technology. So far, thousands of gene mutant mouse models have been constructed using this technolo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/85A01K67/027
CPCA01K67/0276A01K2207/15A01K2217/075A01K2227/105A01K2267/0306C12N15/8509C12N2800/107C12N2800/80A01K67/027C12N15/85
Inventor 高恩侯增淼李晓颖李敏杨小琳赵金礼
Owner SHAANXI HUIKANG BIO TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products